What to Read Next

Pfizer breast cancer drug hits midstage study goal

Linda a. Johnson, AP Business Writer
3 February 2014

Drugmaker Pfizer Inc. said Monday that a midstage study of its experimental drug for advanced breast cancer, palbociclib, met the main goal.

The world's second-biggest drugmaker said the drug, combined with another medicine called letrozole, increased the time patients survived without tumors growing, compared with women just getting letrozole.

Shares of New York-based Pfizer jumped more than 4 percent early on and closed trading up 21 cents at $30.61 while the broader markets fell sharply.

Analysts are closely watching palbociclib, which is for postmenopausal women with certain tumor characteristics found in about 60 percent of patients with advanced breast cancer. It's seen as a potential huge seller.

Credit Suisse analyst Vamil Divan wrote to investors Monday that he expects the drug to produce annual global sales of $2.9 billion in 2023.

"We believe our forecasts are likely conservative at this point," particularly if palbociclib turns out to also work on lung and blood cancers, Divan wrote in a research note.

He reiterated his "Outperform" rating for Pfizer, saying he likes the company's stock "as a multi-year restructuring story" due to possible bonuses from its pipeline of experimental drugs, "shareholder-friendly capital allocation" and a low share price.

Shares had languished in the teens for several years, then nearly doubled from $17.45 over the past 29 months — still well below the share price for Pfizer's major competitors.

Divan noted Pfizer's comments Monday could raise expectations the company could apply for and receive palbociclib approval a little earlier than expected.

Pfizer said it plans to release detailed results from the latest study, called PALOMA-1, at the American Association for Cancer Research meeting in San Diego in early April.

The company is now enrolling patients in a late-stage test of palbociclib. Last April, the Food and Drug Administration designated it a breakthrough therapy, a recognition that helps speed up the review needed for approval.

___

Follow Linda A. Johnson at http://twitter.com/LindaJ_onPharma

VA Mortgage Rates In 2016

VA Rates as Low as 2.75% (3.028% APR) 15 Year Fixed. Exclusive For Veteran & Military Takes 1 Min!

Powerful Tactical Flashlight Flying Off Shelves!

This new tactical flashlight was just released to the public and is flying off shelves in the United States. Limited supplies left, act quick!

Starwood Credit Card

Earn 25,000 Bonus Starpoints®! Use toward Award Nights or Flights.

Ever Googled Someone? Do A "Deep Search" Instead

Entering a Name and State on this site could reveal info you thought wasn't available. Have you searched yourself or someone you know yet?

Bounce Back From The Holidays & Transfer A Balance

Holiday fun means holiday spending. Don't pay interest on your purchases for up to 15 months with the top ranked balance transfer credit cards.

Free Samples Sites- Why You Should Pay Attention

Sign up now for freebies so good you will feel guilty not paying for them! No credit card or purchase necessary.

Insane Navy Seal Flashlight, should it be banned?

The Military has recently released technology that is now available to the public. Get yours before they run out - Limited Supply!

Why You Should Pay Attention to Free Sample Sites

Sign up now for freebies so good you will feel guilty not paying for them! No credit card or purchase necessary.

How to file your taxes right now for $0

It's simple: file your taxes with TurboTax Federal Free Edition and you'll pay $0 for Fed, $0 for State and $0 to File. No tax knowledge needed!

Banks Are Worried Homeowners Will Do This.

Homeowners are surprised and furious. If you owe less than $625,000 on your home, you better read this.

10 Cards for People Who Have Great Credit

What card offers up to 5% cash back? And which one offers 24/7 concierge service? See the best credit cards of 2016. Apply online, quickly & easily.

Controversial Flashlight Should Be Banned?

A Controversial decision to ban this new military flashlight just released to the public could take effect soon. They are selling out quickly, see why

Buying Medicare Supplement Plan F? Read This First

Plan F is the most popular Medicare Supplement plan, but there's another Medigap option you should consider.

Golfers: Hit Straight Every Time

12-Time PGA Winner Shows You How to Hit Longer, Straighter, More Accurately,…